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Regulation of Human  Lung  Fibroblast a1 (I) Procollagen Gene 
Expression  by  Tumor Necrosis Factor a, Interleukin-10, and 
Prostaglandin E2* 
(Received for publication, October 21,  1992, and in revised form, January 14, 1993) 
Arturo Diaz$, Elena Munoz$,  Rosemary Johnston$, Joseph H. Korng, and Sergio A.  JimenezSB 
From  $the  Division of Rheumatology,  Department of Medicine,  Jefferson  Medical College, Thomas  Jefferson  University, 
Philadelphia,  Pennsylvania 19107 and  sthe  Division of Rheumatic  Diseases,  University of Connecticut School of Medicine, 
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We investigated the participation of prostaglandin 
(PG) E2 in the regulation of the al(1) procollagen gene 
expression by tumor necrosis factor a (TNFa), and 
interleukin-18 (IL-18) in normal adult human lung 
fibroblasts. TNFa (100 units/ml) and IL-  18 ( 00 units/ 
ml) stimulated the production of PGEz and caused a 
dose-dependent inhibition of up  to 54 and 66%, respec- 
tively, of the production of type I procollagen. Prein- 
cubation of cultures with indomethacin partially re- 
versed the inhibition of procollagen production in- 
duced  by the cytokines. Cytokine-stimulated endo- 
genous fibroblast PG accounted for 35 and 68% of the 
inhibition induced by TNFa and IL-la, respectively. 
Steady-state mRNA levels for al(1) procollagen par- 
alleled the changes in collagen production. The tran- 
scription rate of the al(1) procollagen gene was re- 
duced  by 58% by TNFa and by 43% by IL-la. Cytokine- 
stimulated endogenous PG production accounted for 
half of these effects. These results indicate that TNFa 
and IL-lB inhibit the expression of the al(1) procolla- 
gen gene in human lung fibroblasts at the transcrip- 
tional level by a PGE2-independent effect as  well as 
through the effect of endogenous fibroblast PGE2 re- 
leased under the stimulus of the cytokines. 
Fibrillar collagens are  the  most  abundant  proteins  in  the 
lung  interstitium  and  constitute  about 15% of the  dry weight 
of the  human  lung (1). Because of the high turnover of the 
connective  tissue of adult  lung  (2),  the  balance between syn- 
thesis  and  degradation  must  be  accurately  controlled  in  order 
to  insure  the  preservation of normal  structure  and  function. 
Exaggerated tissue  deposition of extracellular  matrix  proteins 
is  the  final  outcome of several  diseases in which an  inflam- 
matory process triggered by various stimuli is the earliest 
event  (3).  Tissues undergoing  a chronic  inflammatory process 
are  often  infiltrated by macrophages and lymphocytes. These 
are  the  main cell lineages responsible for  the  production of 
various  cytokines  that  have  been  implicated  in  the  initiation, 
progression, and  eventual  modulation of a variety of inflam- 
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matory  and immunologic  responses. It  has  been shown that 
in addition to their participation in inflammation and the 
immune  response, several cytokines  can  exert  profound effects 
on  fibroblast  production of extracellular  matrix  proteins  (4). 
Thus,  it  is very likely that  they would participate  in  tissue 
remodeling and,  perhaps,  in  the development of fibrosis (2). 
Tumor necrosis factor a (TNFa)’  and  interleukin-lfl  (IL- 
lfl) are  cytokines  produced mainly  by activated cells of the 
monocyte/macrophage lineage. These cytokines have many 
overlapping activities  and play a central role in  inflammation, 
T cell activation,  and cytotoxicity (5 ,  6).  It  is  thought  that 
TNFa  and IL-1fl participate  in  tissue remodeling  because of 
their  ability  to  promote  fibroblast growth and angiogenesis 
and  to  stimulate  the  production f collagenase. Multiple  stud- 
ies have  examined  the effects of TNFa  and/or  IL-1  on  the 
production of extracellular  matrix  proteins by various mes- 
enchymal cells (7-27). In  adult  and  fetal  dermal  fibroblasts, 
TNFa inhibited  the  production of type I and I11 procollagens 
and decreased the levels of their  corresponding  mRNAs (17- 
19,26). However, other  reports showed that  TNFa stimulated 
collagen production in dermal and lung fibroblasts (20, 21, 
25). The effects of IL-1  on  fibroblast collagen production  are 
also controversial.  IL-1  has  been shown both  to increase and 
inhibit collagen production.  These effects were accompanied 
by parallel changes in the steady-state levels of the corre- 
sponding mRNAs in most studies (20, 22-25), although in 
other studies an inhibition of collagen production with a 
paradoxical  increase  in collagen mRNA levels was found  (26, 
27). 
The products of the cyclooxygenase pathway,  such  as PGE2, 
also participate  in  inflammatory  and  immune responses. 
TNFa  and  IL-lp  stimulate  PGE2  production in several cell 
lines including macrophages (28), synovial cells, and fibro- 
blasts (29,  30) and  increase  the  steady-state l vels of cycloox- 
ygenase mRNA (31). There is evidence that PGE2 inhibits 
collagen production  (32) by  several mechanisms, including  a 
reduced uptake of proline (33) and  an  increase  in  the  intra- 
cellular degradation of the protein (34). Furthermore, de- 
creased  steady-state  mRNA levels for al(1) procollagen  have 
been  shown  in  PGEn-treated  fibroblasts,  indicating  that PGE2 
also acts  at  pretranslational levels (35). Several studies have 
examined  the  contribution of increased endogenous PG  pro- 
duction by TNFa  and  IL-1  on  the  modulation of fibroblast 
collagen gene expression (18,  19, 22-27). In only  two  of these 
studies,  it was shown that  PGs play a modulatory role (24, 
27). Because of our  interest  on  the regulation of fibroblast 
* The abbreviations used are: TNFa, tumor necrosis factor a; IL- 
16, interleukin-lp; PG, prostaglandin; PGEZ, prostaglandin Ez; IFNy, 
y-interferon. 
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collagen gene expression by cytokines and cytokine-stimu- 
lated endogenous PG, we conducted the studies presented 
here to clarify the conflicting results described above. We 
postulated that stimulation of fibroblast PGE2 production by 
TNFa  and  IL-lp must play a role in the  net effect of these 
cytokines  on type I collagen production in  a manner similar 
to that shown with TGFB (36). We present evidence that 
TNFa  and  IL-lP  inhibit lung  fibroblast  type  I collagen pro- 
duction and decrease the corresponding  steady-state mRNA 
levels and  that  these effects are mediated by PG-dependent 
and -independent mechanisms. Furthermore, we found that 
TNFa, IL-lP, and PGEz modulation of the  steady-state 
mRNA levels for al(1) procollagen is largely exerted at  the 
transcriptional level. 
MATERIALS  AND  METHODS 
Human Lung Fibroblast Cell Lines-Human lung fibroblast cell 
lines were established from histologically normal lung tissue resected 
for diagnostic purposes, from the left lingula of a 57-year-old white 
female (ID), from the right lung of a 52-year-old white female (PM), 
or from a 20-year-old Caucasian female (CCL-210; purchased from 
ATCC, Rockville, MD). 
Fibroblast Cultures and Labeling  Conditions-Early passage (fifth 
to eighth passage) fibroblasts were plated at a  density of 5 X lo4 cells/ 
well in 24-well flat-bottom plates and cultured in Eagle's minimal 
essential medium supplemented with 10%  fetal calf serum, 1% (v/v) 
vitamin solution (GIBCO) and 2 mM L-glutamine and incubated at 
37 "C in  a 5% CO, atmosphere. The  three cell lines reached confluency 
at  approximately 8-9 days. When the cultures reached confluency, 
the media were removed, and fresh medium containing 5% fetal calf 
serum, 1% (v/v) vitamin solution, 2 mM L-glutamine, and ascorbic 
acid (50 pg/ml) was added. After 24-h incubation, fresh medium 
supplemented with 5% fetal calf serum, 1% (v/v)  vitamin solution, 2 
mM L-glutamine, ascorbic acid (50 pg/ml), and various concentrations 
of human recombinant TNFa (2 X lo7 units/mg, Genentech Inc., San 
Francisco, CA) and human recombinant IL-18 (1 X lo7 units/mg, 
Boehringer Mannheim) alone or in combination was added. Appro- 
priate  cultures were preincubated for 30 min with indomethacin (1 
pg/ml) dissolved in  10 pl of 10%  ethanol or with 10 pl of 10%  ethanol 
alone. After 6 h, 8-aminopropionitrile (100 pg/ml) and 1.5 pCi/ml L- 
[U-"Clproline or 20 pCi/ml~-[6-~H)]glucosamine hydrochloride were 
added, and the incubations were continued for a total of 24 h. In 
other experiments cells were incubated for 24 h with various concen- 
trations of TNFa  and during the last  4  h were incubated in methio- 
nine-deficient media containing 100 pCi/ml ~-[~~S]methionine. At  
the end of the incubations, the media were harvested and a solution 
containing  a mixture of protease inhibitors was added to yield the 
following concentrations: 5 mM EDTA, 0.2 mM phenylmethylsulfonyl 
fluoride, 5 mM N-ethylmaleimide, 1 mM p-aminobenzamidine hydro- 
chloride. Cell monolayers were washed twice with a cold solution of 
0.15 M NaCl, 50 mM Tris-HC1, pH 7.4, and protease inhibitors, and 
the cells were detached mechanically and  then sonicated in the same 
buffer. All experiments were performed in  triplicate. 
Analysis of Labeled Proteins-Aliquots of media and cell layers 
were  dialyzed extensively to remove unincorporated radioactive pre- 
cursors. Total incorporation of ~-[U-'~C]proline,  ~-[~'S]-methionine, 
and D-[6-3H]glucosamine hydrochloride into newly synthesized mac- 
romolecules was measured by scintillation spectroscopy. The  L-[U- 
"Clproline labeled proteins  in the media, and cell layers were ana- 
lyzed by polyacrylamide gel electrophoresis under reducing condi- 
tions. After electrophoresis the gels  were processed for fluorography. 
The fluorographs were scanned with a laser densitometer  (UltroScan 
XL, Pharmacia  LKB Biotechnology Inc.). The amount of radioactive 
collagen synthesized by the fibroblasts was determined by a bacterial 
collagenase assay (37) and  the relative proportions of collagen cal- 
culated following the formula of Breul et al. (38). 
Determination of PGE,-PGE,  was measured in undialyzed sam- 
ples of culture media by a radioimmunoassay as described previously 
(39). 
Isolation and Analysis of Total RNA-Lung fibroblasts were cul- 
tured  in T-75 flasks with increasing concentrations of TNFa or IL- 
18 (0-100 units/ml) for 18 h or with TNFa (100 units/ml) or IL-18 
(50 units/ml) for different intervals up to 24 h. In other experiments 
lung fibroblasts were cultured in T-175 flasks in the presence or 
absence of TNFa (100 units/ml),  IL-18 (50 units/ml), indomethacin 
(1 pg/ml), or PGE, (100 ng/ml) for 24 h. At  the end of the incubations, 
the cell layers were washed in  Hanks' solution and harvested imme- 
diately in  4 M guanidinium isothiocyanate. Total RNA was isolated 
in  a CsC1, discontinuous gradient as described previously (40). For 
Northern blot hybridizations, aliquots containing equal amounts of 
total RNA  were denatured  in formaldehyde, electrophoresed in 0.8% 
agarose/formaldehyde gels, and  then transferred in a vacuum blotting 
system (LKB 2016 VacuGene) to nitrocellulose filters (Optibind S & 
S) and UV-cross-linked (UV Stratalinker 2400, Stratagene). The 
human cDNA clone Hf677 specific for al(1) procollagen (41) and a 
mouse  cDNA specific for glyceraldehyde-3-phosphate dehydrogenase 
(42) were nick-translated with [a-32P]dCTP  to specific activities > 
1.0 X lo8 cpm/pg of DNA. The filters were prehybridized overnight 
and hybridized at  42 "C for 24 h  in 50% formamide, 2 X SSC, 2 X 
Denhart's solution, and 0.1% SDS. For quantitative analysis of the 
mRNA levels, the filters were submitted to autoradiography, and 
autoradiographs were scanned in a laser densitometer. 
In Vitro Nuclear Transcription Assay-The transcription  rate was 
measured by an in vitro nuclear run-off assay as described previously 
(43). Lung fibroblasts were cultured in T-175 flasks for 24 h in the 
presence or absence of TNFa (100 units/ml), IL-1P (50 units/ml), 
indomethacin (1 pg/ml), PGE, (100 ng/ml), or vehicle alone (10 pl/ 
ml 10% ethanol) as described above. At  the end of the incubation 
period, cell layers were trypsinized, and nuclei were prepared as 
described previously (44) and were stored at -70 "C until used. The 
transcription reactions were carried out  in volumes of 100 pl (Exper- 
iment 1) or 300 pl (Experiment 2) in 10 mM Tris, pH 8.0, 90 mM 
KCl,, 3 mM MgCl,, 2 mM dithiothreitol, 1 unitlpl RNasin, 0.4 mM 
each of ATP,  UTP,  and  GTP,  and 0.5  mCi  of [a-"PICTP (Du Pont- 
New England Nuclear, 800 Ci/mmol). Incubations were for 25 min 
at 25 "C, and incorporation of [c~-~'P]CTP was  followed  by trichlo- 
roacetic acid precipitation of 1-p1 aliquots. Transcription was termi- 
nated by the addition of 900 pl of buffer containing 100 mM NaCl, 10 
mM Tris-HC1, pH 7.5, 2 mM KCl, 1 mM EDTA,  and 0.5% SDS. To 
each sample 100 pg  of yeast tRNA was added, and  the samples were 
digested with 100 pg/ml proteinase K for 60 min at 42 "C, extracted 
with phenol/chloroform, and precipitated in 10% trichloroacetic acid 
and 10%  saturated sodium pyrophosphate. The pellets were  washed 
with 70% EtOH, dried, and dissolved in 100  pl of 10 mM Tris-HCI, 
pH 7.4, containing 1 mM EDTA and 0.1% SDS. An additional 100 pg 
of yeast tRNA was added, and nucleic acids were ethanol-precipitated 
in 2.5 M ammonium acetate. The pellets were dissolved in 100 pl of 
buffer that contained 20 mM Tris-HC1, pH 7.5, 10 mM MgCl,, and 2 
mM CaC1, and incubated for 30 min at 37 "C with 100  pg/ml RNase- 
free DNase and 1 unit/pl RNasin. Samples were extracted with 
phenol/chloroform and ethanol-precipitated in 0.3 M sodium acetate. 
Labeled transcripts were resuspended in prehybridization buffer, and 
duplicate 5-pl aliquots were trichloroacetic acid-precipitated and their 
radioactivity determined by scintillation counting. Aliquots of each 
sample containing equal counts/min were adjusted to 400-pl  volume 
by addition of the same buffer and were hybridized to filters contain- 
ing dot-blotted and immobilized purified al(1) procollagen and glyc- 
eraldehyde-3-phosphate dehydrogenase cDNAs in pBR-322 plasmid 
or pBR-322 alone. The dots were previously cut out from the filters 
and prehybridized in 50% formamide, 5 X Denhart's solution, 4 X 
SSC, 0.1% SDS, 0.1  mg/ml salmon sperm DNA. Hybridizations were 
performed with continuous  shaking at 42 "C for 72 h. After hybridi- 
zations, the filters were washed for 15 min in 2 X SSC at room 
temperature and  then for 15 min in 0.2 X SSC at 65  "C and  treated 
with RNase A (10 pg/ml in 2 X SSC) for 15 min at 37 "C. The filters 
were then washed in 2 X SSC, 0.1% SDS for 15 min at room 
temperature and dried. Autoradiographs were obtained and scanned 
in  a laser densitometer. The amount of 32P hybridized to each dot 
blot was determined by scintillation counting. 
RESULTS 
Effects of TNFa and  IL-lp on Collagen Production in the 
Presence or Absence of Indomethacin-Treatment of lung 
fibroblasts with increasing concentrations of TNFa or IL-1p 
resulted in  a  dose-dependent  inhibition of type  I procollagen 
production as analyzed by quantitative densitometry of fluo- 
rographs from SDS-polyacrylamide gel electrophoresis. Fluo- 
rographs of an illustrative  experiment with TNFa are shown 
in Fig. lA and with IL-1p  in Fig. 2 A .  To investigate whether 
the inhibition of type I procollagen production induced by 
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FIG. 1. Effects  of indomethacin on TNFa-induced inhibition 
of type I procollagen production by cultured human lung 
fibroblasts. Confluent human lung fibroblasts (cell line ID) were 
incubated for 24 h with control medium or with media containing 
different  concentrations of TNFa  and were labeled with  L-[U-'~C] 
proline as described under  "Materials  and Methods." Equal  aliquots 
of pooled triplicate samples of media and cell layers were reduced 
with  2-mercaptoethanol,  electrophoresed  on 7% acrylamide gels, and 
processed by fluorography. A, TNFa; B, T N F a  + indomethacin (1 
pg/ml); C, densitometric  analysis of fluorographs  shown  in A (gray 
bars) and B (hatched bars). The integrated areas are expressed in 
arbitrary  densitometric  units (ADU)  as a percentage  relative to values 
from  samples  incubated  with medium  alone. 
TNFa  and IL-10 was related  to  stimulation of endogenous 
fibroblast PG synthesis by the cytokines, parallel cultures 
were preincubated  with indomethacin (1 pg/ml), a concentra- 
tion shown previously to produce  complete inhibition of cy- 
clooxygenase in these cells. The preincubation of cultures 
with indomethacin reversed only partially  the  inhibitory ef- 
fects of TNFa (Fig. 1B) and IL-10 (Fig. 2B) on type I 
procollagen production. Densitometric scanning of fluoro- 
graphs showed a maximal inhibition of newly synthesized 
type I procollagen of  54% at  a concentration of 100 units/ml 
of TNFa.  The  concomitant  treatment of cells with  indometh- 
acin resulted in  an  inhibition of only 35%. Therefore, endog- 
enous  PG accounted  for 35%  of the  total  inhibitory effect of 
TNFa (Fig. IC). 
Similar  analysis showed that 100 units/ml of IL-l@ caused 
a maximal inhibition of 66% on  type I procollagen production. 
The concomitant treatment of cells with indomethacin re- 
sulted in an inhibition of only 21%. Therefore, endogenous 
PG accounted for 68% of the  total  inhibitory effect of IL-1@ 
(Fig. 2C). However, a t  lower concentrations of IL-lP, indo- 
methacin completely abolished IL-10  inhibition of collagen 
production,  suggesting that at these  concentrations,  the col- 
lagen inhibitory effects of the  cytokine  are  entirely  PG-de- 
pendent.  Next, we examined  the effect of the  combination of 
both cytokines  on type I procollagen production. Incubation 
of lung fibroblasts in  the presence of constant  concentrations 
of TNFa  and increasing concentrations of IL-10 showed that 
the  inhibition of procollagen production was more  pronounced 
0 0.1 1 10 100 
I L-1 P CU/m 1 
0 0.1 1 1 0  100 
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FIG. 2. Effects  of indomethacin on IL-10-induced inhibition 
of type I procollagen production by cultured human lung 
fibroblasts. Confluent human lung fibroblasts (cell line ID) were 
incubated for 24 h with control media or with media containing 
different concentrations of IL-lP  and were labeled with L-[U-"C] 
proline as described under  "Materials  and Methods." Equal aliquots 
of pooled triplicate samples of media and cell layers were reduced 
with 2-mercaptoethanol, electrophoresed in 7% acrylamide gels, and 
processed by fluorography. A, IL-1p; B, IL-10 + indomethacin (1 pg/ 
ml); C, densitometric  analysis of fluorographs shown in A (gray  bars) 
and B (hatched  bars). The integrated  areas  are expressed in  arbitrary 
densitometric units ( A D U )  as a percentage relative to values from 
samples  incubated  with medium  alone. 
(72%)  than when the  cultures were incubated with  a single 
cytokine (Fig. 3A). Preincubation of cultures with  indometh- 
acin showed only  a partial reversal of the  inhibitory effect of 
the  combination of both cytokines to 55% (Fig. 3B).  Thus, 
the  contribution of endogenous PG accounted for only 23% 
of the  total  inhibitory effect of that of the combination of 
both cytokines (Fig. 3C). These  results were confirmed by a 
specific collagenase assay in two separate  experiments (Table 
I). 
To exclude the possibility that  the observed effects were 
the result of a global cytotoxic effect of TNFa, cells were 
labeled with [35S]methionine or with [3H]glucosamine. As 
shown in Table 11, incubation of cells with TNFa (100 units/ 
ml) did not affect the incorporation ~f[~~S]methionine to 
total  proteins.  Furthermore,  the incorporation of [ 3 H ] g l u ~ ~ -  
samine into glycoproteins and glycosaminoglycans was in- 
creased in a dose-dependent manner by TNFa, reaching a 
maximal stimulation of 39% at  100 units/ml. In addition, 
trypan blue exclusion showed a  viability  greater than 90% in 
cells cultured  under  either  control conditions  or treated with 
50 or 100 units/ml  TNFa. 
Effects of TNFa and IL-10 on PGE2 Production-As shown 
in  Table 111, incubation of lung fibroblasts  with TNFa (100 
units/ml) caused an increase in PGE, production from 1.06 
to 13.74 ng/ml, and incubation with IL-10 (50 units/ml) 
caused an increase from 2.16 to 30.56 ng/ml. The incubation 
with both cytokines  resulted in higher PGE, production than 
A. 
B. 
C. 
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FIG. 3. Effects of indomethacin on TNFa plus IL-18-in- 
duced inhibition of type I procollagen production by cultured 
human lung fibroblasts. Confluent human lung fibroblasts (cell 
line ID) were incubated for 24 h with control media or with media 
containing 100 units/ml of TNFa plus  different concentrations of IL- 
10 and were  labeled  with ~-[U-’‘C]proline as described  under  “Ma- 
terials and  Methods.”  Equal  aliquots of pooled triplicates of media 
and cell  layers  were  reduced  with 2-mercaptoethanol,  electrophoresed 
on 7% acrylamide  gels, and processed by fluorography.  Control  cul- 
tures were treated with  media with or  without  indomethacin (1 pg/ 
ml). A ,  IL-10 + TNFa; B, IL-10 + TNFa + indomethacin; C, 
densitometric  analysis of fluorographs  shown  in A (gray  bars) and B 
(hatched  bars). The integrated  areas are expressed in arbitrary den- 
sitometric units (ADU) as a percentage relative to values from 
samples  cultured with medium  alone. 
incubation  with  either  cytokine alone. Preincubation of cells 
with  indomethacin completely abolished PGE2 production by 
cells treated  with  TNFa, IL-18, or TNFa plus IL-18 (results 
not  shown). 
Effects of TNFa and IL-10 on al(I) Procollagen mRNA 
Levels-In order  to  investigate  the  mechanisms of the  inhi- 
bition of fibroblast  type I procollagen production by TNFa 
and IL-18, the  steady-state  mRNA levels  for al(1) procollagen 
were examined by Northern  blot  hybridizations  with a specific 
human cDNA. TNFa produced a dose- and  length of incu- 
bation-dependent  reduction of the  steady-state  mRNA levels 
for al(1) procollagen with maximal reduction of 76% at a 
concentration of 100 units/ml (Fig. 4A) and of 67% after 16 
h of incubation  with  the  cytokine (Fig. 4B). 
Northern hybridization analysis of total RNA from lung 
fibroblasts treated with increasing concentrations of IL-18 
showed a dose-dependent  reduction of al(1) procollagen 
steady-state  mRNA levels that  reached a 68% a t  100 units/ 
ml (Fig. 5A). IL-18 induced a length of incubation-dependent 
reduction of al(1) procollagen steady-state  mRNA levels that 
reached 91% a t  24 h (Fig. 5B) .  
Participation of Endogenous PG on  the Reduction of al(I) 
Procollagen mRNA Levels by TNFa and IL-18”To investi- 
gate  the  participation of PG on  the  effects of TNFa  on  the 
al(1) procollagen steady-state  mRNA levels, control  and 
TNFa-treated cells  were incubated  with  or  without  indometh- 
TABLE I 
Effect of indomethacin  on TNFa- and  IL-10-induced  inhibition  of 
total  protein  and collagen production  by  cultured  human  lung 
fibroblasts 
Confluent  human  lung  fibroblasts  (cell  line ID) were  incubated in 
triplicate for 24 h in  control  medium  or in media containing  increasing 
concentrations of TNFa, increasing concentrations of IL-10, or a 
combination of 100 units/ml TNFa with increasing  concentrations 
of IL-10. One set of cultures received indomethacin (1 pg/ml)  dis- 
solved  in ethanol and the other received ethanol  alone.  The  cultures 
were  labeled during the last 18 h with 1.5 pCi of ~-[U-l4C]proline. 
Total protein was determined as described under “Materials and 
Methods.” The values  shown  represent the mean and standard devia- 
tions of triplicate samples.  Collagen  was  determined  by a collagenase 
digestion  assay  employing  equal  aliquots of pooled triplicate  samples 
of media. The numbers in parentheses represent the percentage 
relative to values  from  samples cultured  in  media  alone. 
Total  protein Collagen 
-indomethacin  +indomethacin -indomethacin +indomethacin 
d p m  X d p m  X 
0.0 61.4 f 2.5 68.8 f 6 . 0  29.9 (100.0) 33.5 (112.0) 
0.1 55.3 f 2.7 70.6 f 13.3 27.3 (91.3) 33.9 (113.2) 
1.0 50.5 f 1.3 68.2 f 4 . 0  25.3 (84.4) 32.7 (109.2) 
10.0 53.2 f 4 . 1  70.9 f 3.6 25.7 (85.8) 37.3 (124.5) 
50.0 43.8 f 4.3 69.6 f 4.4 20.2 (67.6) 31.1 (103.9) 
TNFa (units/ml) 
100.0  43.0 f 2.4  57.8 f 2.4  19.4 (64.7) 26.2 (87.4) 
IL-10 (units/ml) 
0.0 84.2 f 3.9 93.6 f 7.0 19.5  (100.0) 22.6 (115.5) 
0.1 84.3 f 4.0 94.9 f 3.0 20.0 (102.5) 21.9 (112.1) 
1.0  76.2 f 3.7 89.3 f 2.9 18.5 (94.6) 20.6 (105.4) 
10.0 60.2 f 5.1 85.3 f 3.6 12.3  (63.0) 18.3  (98.7) 
100.0 50.3 f 1.2 82.8 f 1.4 8.5  (43.5) 15.5  (79.3) 
0.0 70.0 f 2.4 81.6 f 3.2 15.0  (76.9) 17.9  (91.6) 
0.1 60.5 f 5.2 82.8f 4.8 11.4  (58.6) 16.9  (86.3) 
1.0 51.4 f 3.9 75.8+ 3.2 8.9  (45.7) 15.1 (77.2) 
10.0 43.2 f 1.8 72.7 f 5.6 6.2 (32.0) 12.6  (64.4) 
TNFa (100 units/ml) + IL-10 (units/ml) 
TABLE I1 
Effect of TNFa on the incorporation of P5S]methionine  into 
total  protein  and  PHlglucosamine  into glycoprotein 
and glycosaminoglycans 
Confluent  human  lung  fibroblasts  (cell  line  PM) were incubated 
for 24 h in control media  or  in  media containing  increasing  concen- 
trations of TNFa as  described  under  “Materials  and  Methods.” One 
set of samples  was  incubated  in methionine  deficient  media  contain- 
ing 100 pCi/ml ~-[~‘SS]methionine during the last 4 h of culture,  and 
another set of samples was incubated for the last 18 h in media 
containing 20 pCi of D-[6-3H]glucosamine  HCl.  Media  and  cell  layers 
were  harvested together  and processed  as  described  under “Materials 
and Methods.” The values shown represent the mean f S.D. of 
tridicate samdes. 
Total 
protein 
cpm X IO-’ 
0.0 22.7 f 2.2 
10.0 
25.0 
24.4 f 2.5 
23.8 f 1.5 
50.0  24.5 f 2.0 
100.0 24.4 f 0.8 
TNFa (units/ml) 
Glycoproteins and 
glycosaminoglycans 
d p m  X IO-‘ 
1.8 f 0.18 
2.2 f 0.13 
2.2 f 0.09 
2.4 f 0.12 
2.5 f 0.03 
acin or exogenous PGE2 and total RNA was analyzed by 
Northern  hybridizations (Fig. 6). In agreement  with a previous 
report (35), the  treatment of control  cultures with PGE2 (100 
ng/ml)  resulted  in a marked decrease (up  to 60%) of the al(1) 
procollagen steady-state  mRNA levels. Treatment of cultures 
with TNFa (100 units/ml) reduced the al(1) procollagen 
steady-state  mRNA levels by 39%. This decrease was partially 
reversed by preincubation  with  indomethacin,  as only  a 22% 
diminution was observed in  cultures  treated with TNFa plus 
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TABLE 111 
Effect of TNFa and IL-la on PGE, production by cultured  human 
lung fibroblasts 
Confluent human lung fibroblasts (cell line PM) were incubated 
for various intervals  with TNFa  (100 units/ml)  or IL-lP (50 units/ 
ml). At  the  end of the  incubations PGEz was  determined  in  the media 
by radioimmunoassay, and  total  RNA  was  extracted  from cell layers 
for Northern  hvbridizations  shown  in Figs. 4 and 5.  
Time 
PGE2 
TNFn IL-1s 
h 
0 
0.5 
1 
2 
4 
8 
16 
24 
1.06 f 0.32 2.16 k 0.28 
2.06 f 0.62 4.30 f 0.00 
1.92 f 0.5 4.38 k 0.48 
3.78 f 0.62 11.96 f 4.94 
4.14 f 0.08 10.12 f 0.3 
7.32 f 1.08 25.96 f 2.98 
10.68 * 0.86 20.12 f 6.3 
13.74 f 2.84 30.56 & 0.96 
A. 
0 5 10 50 100 
TNFa [U/mll 
- 5.8 kb 
4.8 kb 
B. 
4 5.8 kb 
* 4.8 kb 
0 0.5 1 2 4 8 16 24 
Time [h] 
FIG. 4. Time- and dose-dependent reduction of al(1) pro- 
collagen steady-state mRNA levels by  TNFa in cultured hu- 
man lung fibroblasts. Confluent  human  lung  fibroblasts (cell line 
PM) were incubated for 18 h with  various  concentrations of TNFa  
( A )  or with TNFa  (200 units/ml) for various intervals ( B ) .  Total 
RNA was extracted as described under “Material and Methods.” 
Samples  containing 10 pg of total  RNA were denatured,  electropho- 
resed on a 0.8% agarose gel, and  transferred  to a  nitrocellulose  filter. 
The filter was  hybridized to a radiolabeled human  cDNA specific  for 
al(1) procollagen and processed by autoradiography. 
indomethacin.  Therefore, endogenous PG accounted  for 43% 
of the effect of TNFa.  The  addition of exogenous PGE, (100 
ng/ml) to cultures treated with TNFa  (100 units/ml) plus 
indomethacin (1 pg/ml) resulted in an additive decrease of 
70% on the al(1) procollagen steady-state mRNA levels. 
Incubation of lung  fibroblasts  with  IL-lD  decreased  the al(1) 
procollagen steady-state mRNA levels  by  61%.  However, 
when  IL-lp-treated cells  were preincubated  with  indometha- 
cin  the  al(1) procollagen mRNA  steady-state levels decreased 
by  only 35% (Fig 7). Incubation of cultures  with TNFa  plus 
IL-lP caused a 72% reduction of the steady-state mRNA 
levels for al(1) procollagen. This  inhibition was not reversed 
by preincubation of the  cultures  with  indomethacin,  indicat- 
ing that when the cells were exposed to a combination of 
TNFa plus  IL-lP  at  these  concentrations,  the  main  mecha- 
nisms affecting the al(1) procollagen steady-state mRNA 
levels were PG-independent. 
Effect of TNFa,  IL-ID, and  PGE2  on  the  Transcription  Rate 
of  the al(I) Procollagen Gene-In order  to  investigate  whether 
A. - 5.8 kb 
4.8 kb 
0 5 10 50 100 
k-~O[~/mt l  
B. - 5.8 kb 
4.8 kb 
0 0.5 1 2 4 8 16 24 
Time [ h]  
FIG. 5. Time- and dose-dependent reduction of the crl(1) 
procollagen steady-state mRNA levels by IL-lD in cultured 
human lung fibroblasts. Confluent human lung fibroblasts (cell 
line  PM) were incubated for 18 h with various concentrations of IL- 
18 ( A )  or with 50 units/ml IL-lp for various intervals ( B ) .  Total 
RNA was extracted as described under “Material and Methods.” 
Samples  containing 10 pg of total  RNA were denatured, electropho- 
resed on a 0.8% agarose gel, and  transferred  to a  nitrocellulose  filter. 
The filter was  hybridized to a radiolabeled human cDNA specific for 
al(1) procollagen and processed by autoradiography. kb, kilobase. 
the decrease on the a1(I) procollagen steady-state mRNA 
levels induced  by TNFa  is  mediated by transcriptional mech- 
anisms,  lung  fibroblasts were incubated for 24 h with TNFa 
with  or  without  indomethacin  or  with  PGEz plus indometha- 
cin,  and  the  transcription  rates of the  al(1) procollagen gene 
were measured by an in  vitro nuclear transcription assay. 
Control  cultures were incubated  with  indomethacin  to elimi- 
nate any influence of endogenous PG and allow maximal 
expression of the  al(1) procollagen gene. Treatment of cells 
with  indomethacin  plus  PGE, (100 ng/ml) resulted  in  a 37% 
inhibition of the  transcription  rate of the  al(1) procollagen 
gene (Fig. 8). Treatment of cells with TNFa (100 units/ml) 
resulted in greater  inhibition (58%) of the  transcription  rate 
of the gene. This effect  was partially reversed by the  prein- 
cubation of cells with  indomethacin  (inhibition of only 25%). 
Therefore, endogenous PG  accounted for 57% of the inhibi- 
tory effect of TNFa.  In a separate  experiment  lung fibroblasts 
were incubated with  vehicle alone (EtOH), indomethacin 
alone,  IL-l@  alone,  or  IL-lD  plus  indomethacin (Fig. 8). Cells 
treated  with vehicle alone showed  a  modest inhibition of the 
transcription rate of the al(1) procollagen gene (20%) as 
compared with indomethacin-treated cells. This level of in- 
hibition,  therefore, reflects the level of inhibition induced by 
endogenous PG  under  basal conditions. Treatment with IL- 
lp alone caused a 43% inhibition of the  transcription  rate of 
the  al(1) procollagen gene, and  preincubation of IL-ID-treated 
cultures  with  indomethacin  partially reversed the inhibitory 
effect of IL-lP  to  only  18%.  Therefore, endogenous PG  ac- 
counted for 58% of the inhibitory effect of IL-1fl. These 
observations  indicate  that  the reduction  in the  transcription 
rate of the gene by TNFa  and  IL-lP results from a  combina- 
tion of direct inhibitory effects of the cytokines plus the 
inhibitory effects of endogenous PGE,. 
DISCUSSION 
Here we present evidence that TNFa and IL-10 down- 
regulate the  production of type I procollagen in  normal human 
lung  fibroblasts by modulating  the  steady-state mRNA levels 
A. 
5.8 kb 1 
4.8 kb 1 
Collagen Regulation by TNFa, IL-10, and PGEZ 
1 2 3 4 5 6  
1.3 kb 1 GAPDH 
TNFa + + +  
INDO + +  + +  
PGE2 + + 
1 2 3 4 5 6  
FIG. 6. Effect  of indomethacin and exogenous PGEz on  the 
steady-state mRNA levels for al(1) procollagen in cultured 
human lung fibroblasts treated with TNFa. A ,  confluent  human 
lung fibroblasts (cell line ID) were incubated for 24 h under the 
following conditions. Lane I, no additives; lane 2, indomethacin (1 
pg/ml); lane 3, indomethacin (1 pg/ml) + PGEI (100 ng/ml); lane 4, 
TNFa  (100 units/ml); lane 5, TNFa  (100 units/ml) + indomethacin 
(1 pg/ml); lane 6, TNFa  (100 units/ml) + indomethacin (1 pg/ml) + 
PGE2 (100 ng/ml). Total RNA was extracted as described under 
“Material  and Methods.” Samples  containing 8 pg of total  RNA were 
denatured, electrophoresed on a 0.8% agarose gel, and  transferred  to 
a nitrocellulose  filter. The  same  filter  was hybridized to a  radiolabeled 
human  cDNA specific for al(1) procollagen and  to a murine  cDNA 
specific for glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 
Filters were  processed by autoradiography. B, autoradiographs were 
scanned  in a laser  densitometer. The integrated  areas  are expressed 
in  arbitrary  densitometric  units (ADU)  as a percentage  relative to 
values from samples  cultured  with medium  alone. The numbers under 
the burs correspond  to  the  conditions described in A. 
for  the  protein  and  that  these  effects occur  largely through 
inhibition of transcription. Blockade of endogenous fibroblast 
PG production  reversed  only partially  these effects.  Addition 
of exogenous PGE, reduced the steady-state mRNA levels 
and  the  transcription  rate of the al(1) procollagen gene. These 
results  demonstrate  that  the  inhibitory effect of TNFa  and 
IL-1P on  lung  fibroblast collagen production  is  partially  due 
to  the effects of newly synthesized  fibroblast PG in response 
to   TNFa  and IL-1P stimulation. The inhibitory effects of 
TNFa  were selective for collagen and were not related to 
toxicity as demonstrated by the absence of changes in the 
incorporation of [35S]methionine,  the  increased  synthesis of 
glycosaminoglycans and glycoproteins (20, 45), and  the high 
level of cell viability as  measured by trypan blue  exclusion. 
Although the  results  presented  have clearly demonstrated  an 
effect of IL-1 and  TNFa  on collagen synthesis, an  additional 
mechanism for the  inhibition  on  the  production of collagen 
by TNFa  and IL-1@ must be that of intracellular  and  extra- 
cellular degradation induced  by the  increased  production of 
PG and increased production of collagenase,  respectively (6). 
We found that  the  inhibitory  effects of the  cytokines  on 
the  steady-state  mRNA levels were variable  within  the  same 
cell line (60-90% for IL-1P in PM) or for the  same  cytokine 
in  different cell lines  (TNFa, -70% in PM and 40% in ID). 
A. 
1 2 3  
C. 
1 2 3  
B. 
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FIG. 7. Effect of indomethacin on the steady-state mRNA 
levels for al(1) procollagen in cultured human lung fibroblasts 
treated with IL-lB and TNFa. Confluent  human  lung fibroblasts 
(cell line PM) were incubated for 18 h without ( A )  or with 1 pg/ml 
indomethacin ( B )  under  the following conditions. Lane I, no  addi- 
tives; lane 2, IL-10 (50 units/ml); lune 3, IL-10 (50 units/ml) + TNFa  
(100 units/ml).  Total  RNA was extracted as described under  “Mate- 
rial and Methods.” Samples containing 10 pg of total RNA were 
denatured,  electrophoresed  in a 0.8% agarose gel, and  transferred  to 
a nitrocellulose  filter. The  same filter  was hybridized to a  radiolabeled 
human  cDNA specific  for al(1) procollagen and  to a murine cDNA 
specific  for  glyceraldehyde-3-phosphate  dehydrogenase (GAPDH) 
and processed by autoradiography. Autoradiographs were scanned in 
a laser  densitometer  and  the  integrated  areas expressed in  arbitrary 
densitometric units (ADU)  as a percentage relative to values from 
samples  incubated  in media without  the cytokines. Samples  without 
(C) or  with  indomethacin (D). 
Despite  this  variability,  the ffects of TNFa  and IL-1 on  the 
two cell lines described here and in an additional cell line 
(CCL-210; not shown) were consistently inhibitory on the 
al(1) procollagen gene expression, at  the  three levels exam- 
ined, i.e. rates of gene transcription, steady-state mRNA 
levels, and  protein production. Furthermore  the  participation 
of endogenous prostaglandins on this inhibitory effect was 
found  also at  the  three l vels of protein  biosynthetic pathway 
examined. This consistency makes it very unlikely that a 
clonal selection of a particular cell could be responsible for 
the  results we obtained (46). The discrepancies  with previous 
reports  that  examined  the influence of PG on TNFa  and IL- 
1P effects on collagen production could be due to intrinsic 
differences in  the  ability of different cell types  to produce or 
to respond to endogenous PG. It  is  also possible that under 
particular  experimental  conditions  such  as serum-free or low 
serum  conditions,  the endogenous PG production could be too 
low to  cause  detectable ffects on collagen production. On the 
other  hand, very high concentrations of TNFa or IL-lP or 
their  combination could inhibit  the expression of the procol- 
lagen gene by PG-independent  mechanisms  that  cannot be 
reversed by inhibition of endogenous PG production. The 
observations described  here when cultures were exposed to a 
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FIG. 8. Effects of TNFa and IL-la and PGEz on the tran- 
scription rate of the al(1) procollagen gene in cultured human 
lung fibroblasts. In  two  separate  experiments  (Experiment 1, lanes 
I-4; Experiment 2, lanes 5-8) confluent human lung fibroblasts 
(Experiment 1, cell line ID; Experiment 2, cell line PM) were incu- 
bated for 24 h under  the following conditions. Lane I ,  indomethacin 
(1 pglml); lane 2, indomethacin (1 pg/ml) + PGEZ (100  ng/ml); lane 
3, TNFn (100 units/ml); lane 4, TNFn (100 units/rnl) + indomethacin 
(1 pg/ml); lane 5, vehicle  (10 pl/ml 10% EtOH); lane 6,  indomethacin 
(1 pg/ml); lane 7, IL-10 (50 units/ml); lane 8, IL-10 (50 units/ml) + 
indomethacin (1 pglml). Nuclei  were isolated  and in  oitro transcrip- 
tion  assays performed as described under  “Materials  and Methods.” 
Labeled transcripts from each  sample (3 X lo6 cpm  in  Experiment 1 
and 18 X lo6 cpm in Experiment 2) were hybridized to the filter- 
bound  cDNAs for al(1) procollagen and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) and  to  the  plasmid pBR-322.  After washing 
and digestion with  RNase A, the  filters were  processed by autoradi- 
ography ( A ) ;  autoradiographs were scanned  in a laser  densitometer, 
the pBR-322 background was subtracted, and the integrated areas 
corresponding to hybridized d ( 1 )  procollagen transcripts were nor- 
malized with  the  areas  corresponding  to hybridized  glyceraldehyde- 
3-phosphate dehydrogenase transcripts.  The  resulting  values  are  ex- 
pressed in arbitrary densitometric units ( A D U )  as a percentage 
relative to  values from samples  incubated  with  indomethacin  alone 
( B ) .  
combination of TNFa  plus IL-1P support  this  notion. 
It  has been shown previously that  TNFa  and IL-lD  exert a 
proliferative  response in  fibroblasts  and  that  human alveolar 
macrophages  produced  higher amounts of biologically active 
TNFa  and expressed  higher steady-state TNFa  mRNA levels 
than autologous peripheral blood monocytes  in  response  to 
lipopolysaccharide stimulation (47). Furthermore, TNFa  has 
been implicated in the development of fibrosis in murine 
models (48-50). However, our findings support the notion 
that in the human lung these cytokines may reduce the 
deposition of extracellular  matrix by decreasing collagen  gene 
expression. Therefore,  it  is likely that a more complex network 
of cell to cell and cytokine interactions is required for the 
increased deposition of extracellular  matrix in  lung fibrosis. 
For  example, TNFa  in combination with IL-1  and  interferon- 
y (IFNy)  increases  the  adherence of T-lymphocytes  to  human 
lung  fibroblasts (51), presumably  through  the  induction f the 
intercellular adhesion molecule-1 (ICAM-1). TNFa  in con- 
junction with IFNy induces or amplifies the expression of 
HLA class I1 antigens in monocytes (52) and T cells (53), 
providing an additional mechanism for cell adherence, and 
more importantly,  enhancing  their  antigen  presenting  capa- 
bility. TNFa  and  IL-lP also  increase the expression of high 
affinity IL-2 receptors in T cells (53),  enhancing  their prolif- 
erative response. The macrophage and lymphocyte activation 
caused by TNFa  and IL-1P would stimulate  the production 
of powerful fibrogenic factor(s)  such  as  TGFP by these cells. 
These  cytokine  interactions  turn more  complex if their  inter- 
dependence  with  the  products of arachidonic acid  metabolism 
are considered. In conclusion, in  human lung fibroblasts 
TNFa  and  IL-lP  inhibit  the  production of al(1) procollagen 
largely at the  transcriptional level by PGE2-dependent  and - 
independent mechanisms. Although these cytokines appear 
to be important  mediators  in  the  early  inflammatory  stages 
of lung fibrosis, the  chronic deposition of extracellular  matrix 
proteins  leading to fibrosis must be the  result of more complex 
cellular responses. 
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